Jim Simons's position in Angiodynamic is currently worth $8.99M. That's 0.01% of their equity portfolio (1054th largest holding). The investor owns 1.78% of the outstanding Angiodynamic stock. The first Angiodynamic trade was made in Q2 2013. Since then Jim Simons bought shares 26 more times and sold shares on 26 occasions. The investor's estimated purchase price is $9.38M, resulting in a loss of 4.2%.